OPTIMALPSMA Archives

OPTIMAL-PSMA Trial of TLX597-Tx Next Generation RLT Presented at IPCS 2026 Highlighting Therapeutic Potential in Prostate Cancer

April 30, 2026

TLX597-Tx is a PSMA-targeting small molecule radioligand remedy (RLT) candidate, designed to enhance quality-of-life and efficacy in earlier-stage prostate most ...

Assembly elections 2026 LIVE: Supreme Court disposes TMC’s petition; Alleging unauthorised sorting of postal ballot covers, TMC files complaint with ECI

Grapevine: Real-life miracles | The Jerusalem Post

4,750 drivers charged for driving under the influence of drugs

CM Maryam launches ‘Rehmat Card’ to support widows, orphans with Rs5 billion aid

Tajikistan sees significant increase in light industrial output in 1Q2026

‘Hundreds of applications, no luck’: Fresh grads share job hunt struggles

Why U.S. Officials Are in Venezuela Right Now

Billiards patron Perry Mariano killed in QC attack

AI Performances And Screenplays Won’t Be Eligible For Oscars

After a Maryland teacher’s death, her 200-piece Judaica collection finds new life in a Jewish museum

(2nd LD) Trump says he’s ‘not satisfied’ with Iran proposal, calls Tehran leadership ‘extremely disjointed’

Don”t need to answer critics: Riyan Parag

Tag: OPTIMALPSMA

OPTIMAL-PSMA Trial of TLX597-Tx Next Generation RLT Presented at IPCS 2026 Highlighting Therapeutic Potential in Prostate Cancer

Navigate Site

Welcome Back!

Retrieve your password

Tag: OPTIMALPSMA

Navigate Site

Follow Us

Welcome Back!

Retrieve your password